Katrien E.
- Country
- Belgium
- Department
- pneumology
Research Overview
- Phase 3b/4 Randomized Double‑Blind Study of Depemokimab 100 mg SC Q26 weeks vs Placebo on Exacerbations and Lung‑Function Decline in Adults/Adolescents with Type 2 Asthma
- A Phase 2b, Multicenter, Randomized, Double-blind, Parallel group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 years) with Non-cystic Fibrosis Bronchiectasis
- The IMAGINE study: A phase 3b open label, single arm study to assess the effect of depemokimab on airway structure and function in asthma with Type 2 inflammation characterized by an eosinophilic phenotype utilizing quantitative high-resolution CT and bronchoscopic airway sampling in a sub study
Data & Insights
Has run more than one trial at 42 of 168 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in the treatment of severe asthma, with particular focus on innovative therapeutic approaches for patients with challenging respiratory conditions.
- Asthma Management
- Maintenance Therapy Optimization
- Respiratory Disease Control
Their research interests include evaluation of biological therapies in respiratory medicine and assessment of treatment reduction strategies in controlled asthma patients.
Therapeutic Assessment
The investigator focuses on evaluating maintenance therapy reduction in patients with controlled respiratory conditions, particularly examining long-term disease management strategies.
- Treatment Optimization
- Disease Control Assessment
- Biomarker Monitoring
Their work encompasses the study of biomarker-guided treatment approaches and assessment of sustained disease control in respiratory conditions.
Clinical Applications
The investigator's expertise extends to age-diverse patient populations, working with adolescent through elderly patients in respiratory medicine.
- Adolescent Asthma Care
- Adult Respiratory Medicine
- Long-term Disease Management
Their clinical focus includes development of personalized treatment approaches for different age groups with severe respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.